Sela represents emerging and high-growth companies through all stages of the corporate life cycle – from formation and funding to mergers and acquisitions and public offerings. Additionally, she provides guidance on corporate governance issues and advises venture capital clients on financing transactions.
Cooley advised Halcyon on its $100 million Series C funding. Partner Derek Colla led the Cooley team advising Halcyon, an organization devoted to defeating ransomware through prevention and resilience by way of a proprietary technology that captures encryption keys, enabling organizations to recover from attacks in minutes without paying ransom.
Longboard Pharmaceuticals Announces $2.6 Billion Sale to Lundbeck
October 14, 2024
Cooley advised Longboard Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, on its $2.6 billion sale to Lundbeck.
